Status:

UNKNOWN

POA Retrospective Repository

Lead Sponsor:

Caris Science, Inc.

Conditions:

Oncology

Solid Tumor, Adult

Eligibility:

All Genders

18+ years

Brief Summary

This repository is a multi-center, outcomes study designed to retrospectively collect data on the demographics, presentation, diagnosis, treatment, cost of associated care, quality of life, and outcom...

Detailed Description

This repository is a multi-center, outcomes study designed to retrospectively collect data on the demographics, presentation, diagnosis, treatment, cost of associated care, quality of life, and outcom...

Eligibility Criteria

Inclusion

  • Subject' s age must be greater than or equal to 18 years and must have received CMI testing prior to the initial protocol IRB submission date of November 11, 2016.

Exclusion

  • Due to the complexity of state and federal requirements governing the participation of prisoners in research, prisoners-patients shall not be approached for participation.

Key Trial Info

Start Date :

November 30 2016

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2023

Estimated Enrollment :

10000 Patients enrolled

Trial Details

Trial ID

NCT03326479

Start Date

November 30 2016

End Date

January 1 2023

Last Update

October 31 2017

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Highlands Oncology Group

Fayetteville, Arkansas, United States, 72703

2

Nebraska Cancer Specialists

Omaha, Nebraska, United States, 68130

3

The University of Texas Health Science Center at San Antonio

San Antonio, Texas, United States, 78229